Biomedical Research and Theory Letters

Aims & Scope

Biomedical Research and Theory Letters (BRTL) is an international peer‑reviewed journal dedicated to advancing the frontiers of biomedical science through the integration of theory, experimentation, and clinical application. The journal provides a platform for disseminating high‑quality research that bridges fundamental discoveries in the laboratory with translational and clinical practices, while also encouraging theoretical contributions that enrich the conceptual foundations of biomedical knowledge. By fostering dialogue between empirical research and theoretical frameworks, BRTL seeks to promote innovation, methodological rigor, and interdisciplinary collaboration across the biomedical sciences. The scope of BRTL encompasses a wide range of disciplines, including molecular biology, biochemistry, genetics, physiology, microbiology, and biomedical engineering. The journal also welcomes submissions in clinical medicine, covering areas such as pathology, pharmacology, immunology, oncology, neurology, cardiology, and infectious diseases. Translational research is a central focus, particularly studies on biomarkers, personalized medicine, and novel therapeutic strategies that connect laboratory findings to patient care. In addition, BRTL recognizes the growing importance of bioinformatics, systems biology, and computational modeling, and invites contributions that employ data‑driven approaches to elucidate complex biomedical phenomena. Public health, epidemiology, and evidence‑based health policy are also within the journal’s scope, ensuring that research published in BRTL has both scientific and societal impact.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Subject Classification